Tender Notice for Tab Amlodipine 10 mg,Olopatadine 0.2 per Ophthalmic Soln, bott of 5 ml,Tab Ranitidine HCl IP 300 mg in ALMORA, UTTARAKHAND

The eligibility requirements include being a registered pharmaceutical entity with adequate experience in supplying medication to government or defense sectors. Additionally, bidders must demonstrate financial stability and compliance with technical specifications set forth in the tender documentation.

Bidders must provide relevant certificates demonstrating their compliance with pharmaceutical standards, including manufacturing licenses, quality control certifications, and any other relevant accreditations pertaining to the supplied items.

Bidders can register through the designated procurement platform by creating an account, filling out the necessary information, and submitting all required documentation as per the registration guidelines.

Bidders are required to submit their documents in specified formats that are typically PDF, Word documents, and Excel spreadsheets. The procurement portal will outline the acceptable formats in detail.

The technical specifications for each medication are detailed in the tender documents. They include requirements concerning dosage forms, active ingredients, packaging specifications, and compliance with relevant pharmacopoeias.

Bidders must comply with national and international quality standards applicable to pharmaceutical supplies. This includes adherence to Good Manufacturing Practices (GMP) and other relevant health regulations.

Compliance requirements include adherence to pharmaceutical regulations, submission of valid certifications, and maintaining quality control throughout the supply process, ensuring that all products meet safety and efficacy expectations.

Supplied pharmaceuticals must undergo rigorous testing criteria to ensure they meet safety and efficacy standards as per regulatory practices. This includes quality assurance tests and efficacy tests outlined in the tender documentation.

The Earnest Money Deposit (EMD) is specified in the financial requirements section of the tender. Bidders must submit the specified amount as part of their bid to demonstrate commitment and secure their participation in the tender process.

Yes, performance security requirements must be fulfilled upon the successful awarding of the contract. This ensures that the supplier can meet the obligations of the contract and deliver quality products as specified.

Payment terms will be outlined in the tender documents and usually include conditions for payment post-delivery, with timelines contingent upon the satisfactory receipt of pharmaceutical supplies.

Key timelines, including submission deadlines and bid opening dates, will be specified in the tender documentation to ensure all bidders are well-informed for their timely participation.

The evaluation and selection process involves a comprehensive review of technical submissions followed by financial evaluations. Bids that meet the minimum criteria will be scored based on compliance with technical specifications and overall value.

Notification of results will be communicated through official channels outlined in the tender. Bidders may receive updates via email or through the procurement portal as decisions are made concerning their submissions.

MSEs may benefit from relaxed eligibility criteria, preferred payment terms, and potential price advantages within the evaluation process to enhance their participation in government procurement.

Yes, the tender provides specific provisions for startups to encourage innovation and competitive bids, including potential exemptions and simplified documentation requirements.

This tender supports the 'Make in India' initiative by encouraging local manufacturers and suppliers to participate in government procurement, promoting self-reliance in pharmaceuticals and healthcare products.

Local content and procurement rules will guide the evaluation of bids, prioritizing suppliers that comply with local sourcing requirements and contribute to the domestic economy in alignment with governmental policy directives.